WHO ICTRP trial
A Phase II Study of Chemotherapy Combined with Tyrosine Kinase Inhibitors for…
JPRN-UMIN000011946 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000011946 |
|---|---|
| Public title | A Phase II Study of Chemotherapy Combined with Tyrosine Kinase Inhibitors for Children with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (JPLSG ALL-Ph13). |
| Scientific title | A Phase II Study of Chemotherapy Combined with Tyrosine Kinase Inhibitors for Children with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (JPLSG ALL-Ph13). - A Phase II Study of Chemotherapy with TKI for Children with Ph+ALL (JPLSG ALL-Ph13). |
| Primary sponsor | Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Childhood Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia |
| Interventions | Chemotherapy combined with imatinib or dasatinib. |
| Registration date | Feb 10, 2013 |
| Target size | 44 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: